The FDA announced that β-nicotinamide mononucleotide (β-NMN) is not a legal dietary ingredient, citing its prior investigation as a drug. The Council for Responsible Nutrition (CRN) responded, expressing concern that this decision stifles innovation and disregards consumer interests.